Mesoblast

0 products

Mesoblast is a world leader in regenerative medicine, and develops innovative cellular medicines. It has established one of the industry’s most clinically advanced and diverse portfolio of cell-based products with three programs in active Phase III clinical studies. The Company has used its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells (MLCs), to establish a broad portfolio of late-stage product candidates. These allogeneic, ‘off-the-shelf’ cell product candidates target advanced stages of diseases with high, unmet medical needs including, cardiovascular diseases, immune-mediated and inflammatory conditions, spine orthopaedic disorders, and oncology and haematology diseases. • MPC-06-ID for chronic low back pain due to disc degeneration, • MPC-300-IV for biologic refractory rheumatoid arthritis and diabetic nephropathy